AIATELLA

We’re a #BIHA2024 finalist! Our work to support Doctors in the #prevention, #diagnosis and management of #cardiovasculardisease has been shortlisted at this year’s Bright Ideas in Health Awards! We’re incredibly proud of the team, and it’s an honour to see this work recognised and in the running for the Innovative MedTech award. Congratulations and good luck to all the finalists! We’re looking forward to seeing everyone at the award show in November. The full list of finalists across the ten categories can be found at: https://lnkd.in/gzch9r8 #BIHA2024 David Ripley Anna Beattie Haytham Hamid Saira Malik North East and North Cumbria NHS Health Innovation North East and North Cumbria

We are thrilled to announce our partnership with Nordic Science Investments! Our shared vision for the future of deep tech is what makes this collaboration so exciting. The NSI team understands the challenges and opportunities in commercialising cutting-edge research; and their expertise is invaluable as we work to bring our technology to market - transforming Cardiovascular diagnostics and saving lives! 🚀

We are incredibly excited to announce that Molly O'Neill has joined AIATELLA as an Advisor! Molly’s wealth of experience in strategy for multiple major health institutions including, Duke Health, Tenet Healthcare, Mass General Brigham and proven track record driving growth in venture and private equity backed MedTech, education and care delivery companies, is particularly noteworthy. Her knowledge of the inner workings of the US healthcare ecosystem fills a critical gap in our team. As we expand to North America, her insights into the unique challenges and opportunities of the within US healthcare will be invaluable. "As we continue to build upon our current cardiovascular AI applications and evidence base for our technology, it's now about delivering it to physician users and benefiting patients. By automating the time-consuming and subjective task of measurements, Radiologists and Cardiologists can focus on tasks that require their level of expertise." It's not just Molly's expertise that excites us, but also her alignment with our mission. Like us, she believes in the power of AI to genuinely improve patient outcomes by augmenting clinical workflows; and understands that we must work side-by-side with physicians on the front line to achieve this - "It's one thing to design and implement strategy at the enterprise level, but working with AIATELLA brings me back delivering solutions to the front line. AIATELLA is providing an actionable, precision medicine tool that Radiologists not only want, but need; while immediately benefitting patient care." A warm welcome to the AIATELLA team Molly!

By augmenting cardiovascular care pathways with automation, AIATELLA can directly contribute to the reduction in NHS waiting lists; even enabling ‘same day’ Diagnosis! The support of Health Innovation North East and North Cumbria has been crucial so far to understand the innovation pathway to commercialisation in the NHS. The key, we think, is that we have the same goal (improve patient outcomes) and both understand that there are many cogs to put into place to achieve this. #medtech #aiinhealthcare #cardiovasculardisease #prevention #innovation

Deeptech is a high growth sector with many hyper-scalable opportunities for investors. These are several interesting ones right here in Finland that operate in the clean energy, healthcare and job market sectors, such as Elstor Oy, Soletair Power, Steady Energy, Cactos, Kuva Space, ForteAI, AIATELLA, Adamant Health, StemSight - Vision Unlimited and Marginum. #deeptech

"If it helps the doctors, the consultants and it helps patients, then it's definitely a good thing!" Here is the video from the recent event in which we brought together voices from across the healthcare ecosystem to discuss their perception of #AIinhealthcare, and how AIATELLA could impact the management and prevention of cardiovascular disease. With the support of Health Innovation North East and North Cumbria, we heard from patients with lived experience of cardiovascular disease, Helen Chamberlain of Benenden Health, Dr James Coey of St. George's University and our CEO Jack Parker. The key takeaways: - AI can make a huge impact if it complements Radiologists by addressing a real pain-point (such as manual measurements). - Increasing adoption of AI in healthcare, to enable HCPs to leverage these technologies, requires education. That starts with including AI in the curriculum for the education of the next generation of Doctors. - Shifting from reactive medicine to preventive, requires increasing throughput and capacity, without adding to existing clinical burden. - Patient acceptance of AI in Healthcare is on the rise, with the caveat that they are fully informed as to the role it plays in their care. The event was a testament to the exciting future of AI in healthcare. As we continue to expand the applications of our AI and the patients who could benefit, we move closer to a world where personalised and preventive care is the norm, and cardiovascular diseases are effectively managed and treated. https://lnkd.in/d6qkznV5

We're thrilled to have Daniel Young join our advisory team at AIATELLA! 🙌 As Daniel mentions, radiologists perform roughly one billion examinations worldwide each year, and the task of measuring, interpreting, and reporting the findings is both essential and time-consuming. 📏🫀🩻 Daniel brings a wealth of knowledge and expertise to our team. With 18 years of hands-on experience building technology ventures in the healthcare sector, he is an international expert in quality management and regulatory affairs. 🌍💼 With his extensive experience in radiology AI and his focus on regulatory aspects, Daniel is a valuable asset in our journey through medical device regulations as we develop our AI-powered measurement tools for cardiovascular imaging. 📋✅ We look forward to continue working closely with Daniel and benefiting from his expertise as we strive to reduce subjectivity, increase accuracy, and improve clinical decision-making and patient outcomes in the cardiovascular space. 🎯📈

We are thrilled to announce that AIATELLA is partnering with the esteemed Arizona Heart Foundation. This partnership will leverage our AI technology to develop and scale preventive screening programs for cardiovascular disease. Our collaboration is built on a shared vision and legacy. The Arizona Heart Foundation was founded by the visionary Dr. Edward Diethrich, who tirelessly campaigned for, and embodied the advancement of technology in healthcare. His legacy continues to inspire us as we embark on this journey together. The Arizona Heart Foundation has been a pioneer in #preventivescreening, tirelessly working to detect cardiovascular disease at its earliest stages. Their dedication and commitment to the highest standard of care have saved countless lives, setting a benchmark in the healthcare industry. With AIATELLA’s AI expertise and technology, we will increase the #accessibility of preventive screening, enhance the #precision of diagnosis, and achieve #personalized management of cardiovascular disease. Our AI-driven solutions will enable us to identify risks earlier, intervene more effectively, and ultimately, save more lives. Stay tuned for more updates on this exciting partnership!

Thanks 🦋Claire and to the entire #IoCT team, for your support to date helping us to engage with the people we're building our products for! We can't stress enough the importance of the public & patient voice in the development of medical technologies. The team looks forward to further engagement and with the UK National Innovation Centre for Ageing and developing our technology in the realm of #longevity

🎉 Exciting news from our team! - Evidence-based AI We’re thrilled to announce the recent publication of our proof-of-concept study in the Cureus Journal of Medical Science. Read it here: https://lnkd.in/d2JhAD3t We conducted the study in collaboration with the Northumbria Healthcare NHS Foundation Trust, supported by Northumbria University, St. George's University International School of Medicine, and University of Sunderland. Our study showcased the performance of the AIATELLA tool in the assessment of Cardiac MR imaging of the aortic root and valve. The tool was compared against three consultant cardiologists, demonstrating that it is as accurate as the cardiologists and can therefore be relied upon. What’s more, our AI tool produced results over 100x faster than the human experts in the study! This is a promising step forward for our AI, showing its potential to increase the efficiency of care delivery in Cardiovascular medicine. Our next steps are to validate our tool in a large, global cohort to demonstrate its generalisability. We’re fortunate to have research partners in the North East from the NHS, and internationally in Europe, the US, and India, who will be instrumental in this next phase. Stay tuned for more updates as we continue to push the boundaries of AI in healthcare! #aiinhealthcare #radiology #evidencebased #publication